To Study The Effect Of Hingu Churna In Ovulationâ??
- Conditions
- Health Condition 1: E00-E89- Endocrine, nutritional and metabolic diseases
- Registration Number
- CTRI/2022/10/046207
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Females with irregular and Scanty menses due to anovulatory cycle
2. WHO Group II anovulatory cycles i.e. Normogonadotrophic Hypogonadism, most common of which is PCOD
3. Pre-diagnosed patients of anovulatory cycles
1. Age less than 18 years and more than 35 years 2. WHO Type I and Type III Anovulatory Disorders 3. Patients with infertility cause other than follicular development 4. Endometriosis 5. Untreated and Uncontrolled Hyper Prolactinemia 6. Hypo and Hyper Gonadotropin, level 7. Uterine Fibroid 8. Ovarian Tumor 9. Any other non-ovarian Causes of abnormality in ovarian follicle Development.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes that will be assessed- Ovarian follicle developmentTimepoint: 3 menstrual cycles
- Secondary Outcome Measures
Name Time Method There are no secondary outcomes to be measuredTimepoint: Not applicable